HighTower Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
HighTower Advisors's RDY Position: Q3 2026 in Review
HighTower Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 21% in Q3 2026, selling an estimated $105K and leaving 30,832 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2961.
HighTower Advisors first reported a position in RDY in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.48M in Q3 2015. 236 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- HighTower Advisors held 30,832 shares of Dr. Reddy's Laboratories worth $389K as of Q3 2026.
- HighTower Advisors sold 8,444 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $105K.
- Dr. Reddy's Laboratories made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2961 holding.
- HighTower Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 23 quarters since.
- HighTower Advisors's Dr. Reddy's Laboratories position peaked at $2.48M in Q3 2015.
- 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.